Clinical and Experimental Advances in Treatment of Visceral Leishmaniasis
Top Cited Papers
- 1 August 2001
- journal article
- review article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 45 (8), 2185-2197
- https://doi.org/10.1128/aac.45.8.2185-2197.2001
Abstract
No abstract availableThis publication has 202 references indexed in Scilit:
- Miltefosine, an Oral Agent, for the Treatment of Indian Visceral LeishmaniasisNew England Journal of Medicine, 1999
- Immunochemotherapy for Leishmania donovani Infection in Golden Hamsters: Combinatorial Action of Poly ICLC Plus L-Arginine and Sodium Stibogluconate (Stibanate®)Journal of Interferon & Cytokine Research, 1999
- Visceral Leishmaniasis (Kala‐azar) in Solid Organ Transplantation: Report of Five Cases and ReviewClinical Infectious Diseases, 1999
- Leishmania donovani infection initiates T cell-independent chemokine responses, which are subsequently amplified in a T cell-dependent mannerEuropean Journal of Immunology, 1999
- Modulating ongoing Th2-cell responses in experimental leishmaniasisParasitology Today, 1997
- Leishmania donovani in hamsters: Stimulation of non-specific resistance by novel lipopeptides and their effect in antileishmanial therapyCellular and Molecular Life Sciences, 1995
- Practical progress and new drugs for changing patterns of leishmaniasisParasitology Today, 1993
- Determinants of the immune response in visceral leishmaniasis: Evidence for predominance of endogenous interleukin 4 over interferon-γ productionClinical Immunology and Immunopathology, 1990
- Treatment of Visceral Leishmaniasis with Pentavalent Antimony and Interferon GammaNew England Journal of Medicine, 1990
- Sugar receptor mediated drug delivery to macrophages in the therapy of experimental visceral leishmaniasisBiochemical and Biophysical Research Communications, 1990